Surgical treatment of chest wall tuberculosis_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

WU Banggui ,  JIANG Liangshuang , ZHONG Ming , GONG Sheng , JIA Shuang , LI Xiao , LIU Chao

Department of Thoracic Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, 610066, P.R.China;

Corresponding?author：

JIANG Liangshuang, Email: hdnhuqivn@163.com

Keywords：

Chest wall tuberculosis; surgery; recurrence

DOI：

10.7507/1007-4848.202001050

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the effect of surgical treatment on chest wall tuberculosis.Methods A total of 407 patients with chest wall tuberculosis who met the inclusion and exclusion criteria from April 2008 to December 2017 in Chengdu Public Health Clinical Medical Center were enrolled. They were divided into two groups according to the time of admission: a control group (203 patients admitted from April 2008 to December 2012) treated with traditional focus debridement, including 135 males and 68 females, with an average age of 40.65±4.68 years, and an observation group (204 patients admitted from 2013 to 2017) undergoing complete focus debridement, including 139 males and 65 females, with an average age of 40.73±4.72 years. The general clinical data, perioperative related indexes, incision healing, incidence of complications and recurrence between the two groups were compared.Results There was no significant difference in general clinical data, operation time, postoperative pain time, extubation time, hospital stay or recurrence rate between the two groups (P>0.05), but compared with the control group the grade A healing rate in the observation group was significantly higher and incidence of complications was significantly lower (P<0.05).Conclusion Thorough debridement can achieve a better effect in the treatment of chest wall tuberculosis, and help to reduce complications and promote wound healing. It is suitable for clinical application.

Citation： WU Banggui, JIANG Liangshuang, ZHONG Ming, GONG Sheng, JIA Shuang, LI Xiao, LIU Chao. Surgical treatment of chest wall tuberculosis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2020, 27(10): 1207-1210. doi: 10.7507/1007-4848.202001050 Copy

1.	仲毅. 胸壁結核術后切口愈合不良的相關因素研究. 安徽醫科大學, 2019.
2.	仲毅, 盧興時, 陳康, 等. 胸壁結核診斷及治療的研究現狀. 中國胸心血管外科臨床雜志, 2019, 26(9): 926-932.
3.	Subotic D, Yablonskiy P, Sulis G, <italic>et al</italic>. Surgery and pleuro-pulmonary tuberculosis: a scientific literature review. J Thorac Dis, 2016, 8(7): E474-E485.
4.	宋東梅. 超聲造影在胸壁結核穿刺活檢中的應用價值. 中國當代醫藥, 2017, 24(6): 68-70.
5.	蔡偉鵬. 超聲引導經皮穿刺治療在胸壁結核患者中的應用價值. 中國藥物經濟學, 2017, 12(2): 110-112.
6.	羅小英, 劉姝, 岳冀, 等. 108 例胸壁結核的超聲影像表現分析. 實用醫院臨床雜志, 2016, 13(5): 198-200.
7.	姜友定, 連貴勇, 陳穗, 等. 363 例胸壁結核性膿腫的手術治療總結. 嶺南現代臨床外科, 2015, 15(6): 652-655.
8.	劉興元, 徐翼, 紀沛君, 等. 手術治療復發性胸壁結核的效果評價. 西部醫學, 2018, 30(11): 1607-1611.
9.	張衛東, 魏金星, 劉淵源, 等. 術前超短程化療聯合手術治療胸壁結核的療效觀察. 中國胸心血管外科臨床雜志, 2018, 25(10): 865-869.
10.	周雨, 梁雄斌, 游長勝, 等. 胸腺五肽聯合常規抗結核治療在胸壁結核術后患者中的應用效果觀察. 白求恩醫學雜志, 2017, 15(6): 746-748.
11.	何鋒, 張霓, 付向寧. 帶蒂大網膜在難治性胸壁結核外科治療中的應用. 中國繼續醫學教育, 2018, 10(20): 75-77.
12.	Alexander GR, Biccard B. A retrospective review comparing treatment outcomes of adjuvant lung resection for drug-resistant tuberculosis in patients with and without human immunodeficiency virus co-infection. Eur J Cardiothorac Surg, 2016, 49(3): 823-828.
13.	韓亢. 胸壁結核合并胸膜炎的外科治療體會. 吉林醫藥學院學報, 2016, 37(4): 280-281.
14.	Han YI, Zhao Q, Yu D, <italic>et al</italic>. Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery. Exp Ther Med, 2015, 9(4): 1433-1437.
15.	Umanah TA, Ncayiyana JR, Nyasulu PS. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa. Trans R Soc Trop Med Hyg, 2015, 109(5): 340-348.
16.	單國際. 伴有肋骨破壞的胸壁結核減創手術治療體會. 中國醫師進修雜志, 2018, 41(6): 541-542.

1. 仲毅. 胸壁結核術后切口愈合不良的相關因素研究. 安徽醫科大學, 2019.
2. 仲毅, 盧興時, 陳康, 等. 胸壁結核診斷及治療的研究現狀. 中國胸心血管外科臨床雜志, 2019, 26(9): 926-932.
3. Subotic D, Yablonskiy P, Sulis G, <italic>et al</italic>. Surgery and pleuro-pulmonary tuberculosis: a scientific literature review. J Thorac Dis, 2016, 8(7): E474-E485.
4. 宋東梅. 超聲造影在胸壁結核穿刺活檢中的應用價值. 中國當代醫藥, 2017, 24(6): 68-70.
5. 蔡偉鵬. 超聲引導經皮穿刺治療在胸壁結核患者中的應用價值. 中國藥物經濟學, 2017, 12(2): 110-112.
6. 羅小英, 劉姝, 岳冀, 等. 108 例胸壁結核的超聲影像表現分析. 實用醫院臨床雜志, 2016, 13(5): 198-200.
7. 姜友定, 連貴勇, 陳穗, 等. 363 例胸壁結核性膿腫的手術治療總結. 嶺南現代臨床外科, 2015, 15(6): 652-655.
8. 劉興元, 徐翼, 紀沛君, 等. 手術治療復發性胸壁結核的效果評價. 西部醫學, 2018, 30(11): 1607-1611.
9. 張衛東, 魏金星, 劉淵源, 等. 術前超短程化療聯合手術治療胸壁結核的療效觀察. 中國胸心血管外科臨床雜志, 2018, 25(10): 865-869.
10. 周雨, 梁雄斌, 游長勝, 等. 胸腺五肽聯合常規抗結核治療在胸壁結核術后患者中的應用效果觀察. 白求恩醫學雜志, 2017, 15(6): 746-748.
11. 何鋒, 張霓, 付向寧. 帶蒂大網膜在難治性胸壁結核外科治療中的應用. 中國繼續醫學教育, 2018, 10(20): 75-77.
12. Alexander GR, Biccard B. A retrospective review comparing treatment outcomes of adjuvant lung resection for drug-resistant tuberculosis in patients with and without human immunodeficiency virus co-infection. Eur J Cardiothorac Surg, 2016, 49(3): 823-828.
13. 韓亢. 胸壁結核合并胸膜炎的外科治療體會. 吉林醫藥學院學報, 2016, 37(4): 280-281.
14. Han YI, Zhao Q, Yu D, <italic>et al</italic>. Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery. Exp Ther Med, 2015, 9(4): 1433-1437.
15. Umanah TA, Ncayiyana JR, Nyasulu PS. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa. Trans R Soc Trop Med Hyg, 2015, 109(5): 340-348.
16. 單國際. 伴有肋骨破壞的胸壁結核減創手術治療體會. 中國醫師進修雜志, 2018, 41(6): 541-542.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Surgical treatment of chest wall tuberculosis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content